UniProt ID | A2AP_HUMAN | |
---|---|---|
UniProt AC | P08697 | |
Protein Name | Alpha-2-antiplasmin | |
Gene Name | SERPINF2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 491 | |
Subcellular Localization | Secreted. | |
Protein Description | Serine protease inhibitor. The major targets of this inhibitor are plasmin and trypsin, but it also inactivates matriptase-3/TMPRSS7 and chymotrypsin.. | |
Protein Sequence | MALLWGLLVLSWSCLQGPCSVFSPVSAMEPLGRQLTSGPNQEQVSPLTLLKLGNQEPGGQTALKSPPGVCSRDPTPEQTHRLARAMMAFTADLFSLVAQTSTCPNLILSPLSVALALSHLALGAQNHTLQRLQQVLHAGSGPCLPHLLSRLCQDLGPGAFRLAARMYLQKGFPIKEDFLEQSEQLFGAKPVSLTGKQEDDLANINQWVKEATEGKIQEFLSGLPEDTVLLLLNAIHFQGFWRNKFDPSLTQRDSFHLDEQFTVPVEMMQARTYPLRWFLLEQPEIQVAHFPFKNNMSFVVLVPTHFEWNVSQVLANLSWDTLHPPLVWERPTKVRLPKLYLKHQMDLVATLSQLGLQELFQAPDLRGISEQSLVVSGVQHQSTLELSEVGVEAAAATSIAMSRMSLSSFSVNRPFLFFIFEDTTGLPLFVGSVRNPNPSAPRELKEQQDSPGNKDFLQSLKGFPRGDKLFGPDLKLVPPMEEDYPQFGSPK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
36 | O-linked_Glycosylation | EPLGRQLTSGPNQEQ CCCCCCCCCCCCHHH | 24.25 | OGP | |
36 | Phosphorylation | EPLGRQLTSGPNQEQ CCCCCCCCCCCCHHH | 24.25 | 28509920 | |
37 | Phosphorylation | PLGRQLTSGPNQEQV CCCCCCCCCCCHHHC | 61.93 | 28509920 | |
37 | O-linked_Glycosylation | PLGRQLTSGPNQEQV CCCCCCCCCCCHHHC | 61.93 | OGP | |
45 | O-linked_Glycosylation | GPNQEQVSPLTLLKL CCCHHHCCCEEEEEC | 17.56 | OGP | |
48 | Phosphorylation | QEQVSPLTLLKLGNQ HHHCCCEEEEECCCC | 33.17 | 28509920 | |
48 | O-linked_Glycosylation | QEQVSPLTLLKLGNQ HHHCCCEEEEECCCC | 33.17 | OGP | |
126 | N-linked_Glycosylation | HLALGAQNHTLQRLQ HHHHHCCCHHHHHHH | 29.58 | UniProtKB CARBOHYD | |
126 | N-linked_Glycosylation | HLALGAQNHTLQRLQ HHHHHCCCHHHHHHH | 29.58 | 16335952 | |
250 | Phosphorylation | NKFDPSLTQRDSFHL CCCCCCCCCCCCCCC | 26.37 | 20068231 | |
295 | N-linked_Glycosylation | AHFPFKNNMSFVVLV EECCCCCCEEEEEEE | 28.24 | UniProtKB CARBOHYD | |
295 | N-linked_Glycosylation | AHFPFKNNMSFVVLV EECCCCCCEEEEEEE | 28.24 | 16335952 | |
309 | N-linked_Glycosylation | VPTHFEWNVSQVLAN EECCCCCCHHHHHHH | 19.16 | UniProtKB CARBOHYD | |
309 | N-linked_Glycosylation | VPTHFEWNVSQVLAN EECCCCCCHHHHHHH | 19.16 | 16335952 | |
316 | N-linked_Glycosylation | NVSQVLANLSWDTLH CHHHHHHHCCCCCCC | 30.37 | UniProtKB CARBOHYD | |
316 | N-linked_Glycosylation | NVSQVLANLSWDTLH CHHHHHHHCCCCCCC | 30.37 | 2440681 | |
390 | Ubiquitination | TLELSEVGVEAAAAT EEEHHHHHHHHHHHH | 13.90 | 29967540 | |
397 | O-linked_Glycosylation | GVEAAAATSIAMSRM HHHHHHHHHHHHHHC | 18.88 | OGP | |
397 | Phosphorylation | GVEAAAATSIAMSRM HHHHHHHHHHHHHHC | 18.88 | - | |
398 | Phosphorylation | VEAAAATSIAMSRMS HHHHHHHHHHHHHCC | 12.01 | - | |
405 | Phosphorylation | SIAMSRMSLSSFSVN HHHHHHCCHHHCCCC | 24.80 | - | |
407 | Phosphorylation | AMSRMSLSSFSVNRP HHHHCCHHHCCCCCC | 23.25 | - | |
410 | Phosphorylation | RMSLSSFSVNRPFLF HCCHHHCCCCCCEEE | 22.04 | - | |
450 | Phosphorylation | ELKEQQDSPGNKDFL HHHHCCCCCCCHHHH | 30.30 | 24505115 | |
454 | Ubiquitination | QQDSPGNKDFLQSLK CCCCCCCHHHHHHHC | 56.63 | 29967540 | |
459 | Phosphorylation | GNKDFLQSLKGFPRG CCHHHHHHHCCCCCC | 33.91 | 24972180 | |
459 | O-linked_Glycosylation | GNKDFLQSLKGFPRG CCHHHHHHHCCCCCC | 33.91 | OGP | |
484 | Phosphorylation | VPPMEEDYPQFGSPK CCCCCCCCCCCCCCC | 11.38 | 2434496 | |
484 | Sulfation | VPPMEEDYPQFGSPK CCCCCCCCCCCCCCC | 11.38 | - | |
484 | Sulfation | VPPMEEDYPQFGSPK CCCCCCCCCCCCCCC | 11.38 | 2434496 | |
489 | Phosphorylation | EDYPQFGSPK----- CCCCCCCCCC----- | 30.70 | 24719451 | |
489 | O-linked_Glycosylation | EDYPQFGSPK----- CCCCCCCCCC----- | 30.70 | OGP |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of A2AP_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of A2AP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of A2AP_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CFAD_HUMAN | CFD | physical | 12080056 | |
SSRA_HUMAN | SSR1 | physical | 21988832 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
262850 | Alpha-2-plasmin inhibitor deficiency (APLID) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-126; ASN-295 AND ASN-309,AND MASS SPECTROMETRY. |